A two-day international symposium to commemorate 100 years since the discovery of the condition

The meeting is supported by:

The British Association for the Study of the Liver & the British Society of Gastroenterology

Earlybird discount registration is now open and ends at midnight on Friday 31 August

Places are limited to 125 with bookings accepted on a first-come-first-served basis.

It will commemorate 100 years since the discovery of the condition by Dr Alexander Kinnier Wilson in 1912 when he published his paper in the medical journal Brain: Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver.

Aimed at clinicians and scientists professionals from hepatology, gastroenterology, neurology, psychiatry, haematology, cell biology and molecular genetics.

An international cast of expert speakers has been drawn from across Europe, North America India and the UK.

Presentations will review the clinical features and algorithms for the diagnosis of Wilson’s disease, as well as the current best practice for its treatment.

Experts in cellular and molecular biology will present the latest research on copper handling in Wilson’s disease, the relationship between ATP7B genotype and clinical disease, and experimental approaches being studied to correct the metabolic defect.

Bookings are being accepted on a first-come-first-served basis.

Early-bird (until midnight 31 August) £325 (including VAT) After 31st August £395 (including VAT)

The delegate price includes lunch and refreshments for two days.

For more information please contact the Conference Secretariat: This e-mail address is being protected from spambots. You need JavaScript enabled to view it or telephone: +441273 622212

Detailed programme to be published shortly.

Topics to be covered will include:

• Historical aspects of Wilson's disease
• Copper handling and metabolism
• ATP7B gene structure, function and dysfunction
• Hepatic and neuropsychiatric features of Wilson’s disease (individual sessions)
• The diagnostic route
• Clinical assessment methodology
• Putative genotype/phenotype associations
• Screening of siblings and children
• Care networks
• Treatment options (with debate)
• Liver transplantation
• Monitoring treatment
• Management of neurological deterioration on treatment and during pregnancy
• Research in hepatocyte transplantation

Confirmed speakers:

Prof Fred Askari, Ann Arbor, USA
Dr Mohit Bhatt, Mumbai, India
Professor Anna Czlonkowska, Warsaw, Poland
Prof Anil Dhawan, London, UK
Dr Peter Ferenci, Vienna, Austria
Dr Godfrey Gillett, Sheffield, UK
Dr Dominik Huster, Leipzig, Germany
Mr James Kinnier Wilson, Cambridge, UK
Prof Niall Quinn, London, UK
Dr Edward Reynolds, London, UK
Dr Eve Roberts, Toronto, Canada
Dr Michael Schilsky, Yale, USA
Prof Hartmut Schmidt, Munster, Germany
Professor Stuart Tanner, Sheffield, UK
Dr Jean-Marc Trocello, Paris, France
Dr John Walshe, Cambridge, UK
Dr Karl Weiss, Heidelberg, Germany